The Safety Profile of Vitamin D Supplements Using Real-World Data from 445,493 Participants of the UK Biobank: Slightly Higher Hypercalcemia Prevalence but Neither Increased Risks of Kidney Stones nor Atherosclerosis
Nutrients · 2024
DOI: 10.3390/nu16142251 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Sha Sha und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Hauptthemen laut MEDLINE: Hypercalcemia, Vitamin D, Dietary Supplements, Kidney Calculi. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Welsh Assembly Government, British Heart Foundation, Cancer Research UK.
Abstract (Originalsprache)
Background
Potential calcium-related adverse events of vitamin D supplement use have not been addressed in large-scale, real-world data so far.
Methods
Leveraging data from the UK Biobank, encompassing 445,493 individuals aged 40–69, we examined associations of high 25-hydroxyvitamin (25(OH)D) levels ≥ 100 nmol/L and vitamin D supplementation with hypercalcemia (serum calcium > 2.6 mmol/L), kidney stones, and atherosclerosis assessments (pulse wave arterial stiffness index and carotid intima-medial thickness). Regression models were comprehensively adjusted for 49 covariates.
Results
Approximately 1.5% of the participants had high 25(OH)D levels, 4.3% regularly used vitamin D supplements, and 20.4% reported regular multivitamin use. At baseline, the hypercalcemia prevalence was 1.6%, and 1.1% was diagnosed with kidney stones during follow-up. High 25(OH)D levels were neither associated with calcium-related adverse events nor atherosclerosis assessments. Vitamin D and multivitamin supplementation were associated with an increased prevalence of hypercalcemia (odds ratios and 95% confidence intervals: 1.46 [1.32–1.62] and 1.11 [1.04–1.18], respectively) but were neither associated with atherosclerosis nor future kidney stones.
Conclusions
High 25(OH)D levels observable in routine care were not associated with any adverse outcome. Vitamin D users have a slightly higher prevalence of hypercalcemia, possibly due to co-supplementation with calcium, but without a higher atherosclerosis prevalence or risk of kidney stones.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
- Faculty of Medicine, University of Heidelberg, 69115 Heidelberg, Germany.
- Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.
- German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
ORCID-Profile: Miriam Degen, Tomislav Vlaski, Hermann Brenner, Ben Schöttker
Förderung
- Welsh Assembly Government
- British Heart Foundation
- Cancer Research UK
- Diabetes UK
- National Health Service (NHS)
Zitieren
APA
Sha, S., Degen, M., Vlaski, T., Fan, Z., Brenner, H., & Schöttker, B. (2024). The Safety Profile of Vitamin D Supplements Using Real-World Data from 445,493 Participants of the UK Biobank: Slightly Higher Hypercalcemia Prevalence but Neither Increased Risks of Kidney Stones nor Atherosclerosis. Nutrients. https://doi.org/10.3390/nu16142251
Vancouver
Sha S, Degen M, Vlaski T, Fan Z, Brenner H, Schöttker B. The Safety Profile of Vitamin D Supplements Using Real-World Data from 445,493 Participants of the UK Biobank: Slightly Higher Hypercalcemia Prevalence but Neither Increased Risks of Kidney Stones nor Atherosclerosis. Nutrients. 2024. doi:10.3390/nu16142251
BibTeX
@article{Sha2024,
author = {Sha, Sha and Degen, Miriam and Vlaski, Tomislav and Fan, Ziwen and Brenner, Hermann and Schöttker, Ben},
title = {The Safety Profile of Vitamin D Supplements Using Real-World Data from 445,493 Participants of the UK Biobank: Slightly Higher Hypercalcemia Prevalence but Neither Increased Risks of Kidney Stones nor Atherosclerosis},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16142251}
}
EUVIMED